Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHP will modify Orudis KT implied overall superiority claim in future ads -- NAD.

This article was originally published in The Tan Sheet

Executive Summary

AHP ORUDIS KT "UNINTENDED" OVERALL SUPERIORITY CLAIM over other headache medicines should be eliminated in future advertising, the National Advertising Division of the Council of Better Business Bureaus said in an Aug. 29 NAD Case Report. American Home Products disagreed with NAD's decision but said that it would not appeal because the series of television commercials has been discontinued "in the ordinary course of business." The company agreed to take NAD's comments into account when developing new ads.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085965

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel